Search Results 371-380 of 17732 for SC

  1. Melanoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  2. Vasculitis Clinical Trials - Mayo Clinic Research

    The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 mg SC every 4 ...

  3. A Study Of The Efficacy And Safety Of Upadacitinib (ABT-494) In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    ... SC dose at Week 2 [or one 80 mg SC dose at Baseline, followed by one 40 mg SC dose at Week 2, in countries where this dosing regimen is approved]); OR; At ...

  4. Publications - Brad S. Karon, M.D., Ph.D. - Mayo Clinic

    Epub 1900 Jan 01. Karon BS, Meeusen JW, Bryant SC. Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After ...

  5. Sharing Mayo Clinic: Individualized cancer treatment through Mayo Clinic Care Network

    A patient of Carolinas Hospital System in Florence, South Carolina, part of the Mayo Clinic Care Network, Andrew had a consult with oncologist Ziad Skaff, M.D., ...

  6. Glucagon (injection route) - Side effects & dosage - Mayo Clinic

    Glucagon injection is an emergency medicine used to treat severe hypoglycemia (low blood sugar) in diabetes patients treated with insulin who have passed out or ...

  7. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

    This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects ...

  8. Knee Arthritis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the safety of sc-rAAV2.5IL-1Ra, a gene therapy carried by a virus and delivered by injection into the knee joint of ...

  9. Collaborators - Cellular and Molecular Physiology of Gastrointestinal Disorders Laboratory - Mayo Clinic Research

    Georgine Faulkner, Ph.D. International Centre for Genetic Engineering and Biotechnology Trieste, Italy; Braden Kuo, M.D., M.Sc. Massachusetts General Hospital

  10. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, Jatoi A, Dowdy SC, Podratz KC. Risk-adjusted outcomes in elderly endometrial cancer ...